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Clinical and Imaging Evaluation of
Nipple Discharge
Yi-Hong Chou, Chui-Mei Tiu*, Chii-Ming Chen1
Nipple discharge, the spontaneous release of fluid from the nipple, is a common presenting
finding that may be caused by an underlying intraductal or juxtaductal pathology,
hormonal imbalance, or a physiologic event. Spontaneous nipple discharge must be
regarded as abnormal, although the cause is usually benign in most cases. Clinical
evaluation based on careful history taking and physical examination, and observation
of the macroscopic appearance of the discharge can help to determine if the discharge
is physiologic or pathologic. Pathologic discharge can frequently be uni-orificial, localized
to a single duct and to a unilateral breast. Careful assessment of the discharge is mandatory,
including testing for occult blood and cytologic study for malignant cells. If the discharge
is physiologic, reassurance of its benign nature should be given. When a pathologic
discharge is suspected, the main goal is to exclude the possibility of carcinoma, which
accounts for only a small proportion of cases with nipple discharge. If the woman has
unilateral nipple discharge, ultrasound and mammography are frequently the first investigative
steps. Cytology of the discharge is routine. Ultrasound is particularly useful for localizing
the dilated duct, the possible intraductal or juxtaductal pathology, and for guidance of
aspiration, biopsy, or preoperative wire localization. Galactography and magnetic resonance
imaging can be selectively used in patients with problematic ultrasound and mammography
results. Whenever there is an imaging-detected nodule or focal pathology in the duct
or breast stroma, needle aspiration cytology, core needle biopsy, or excisional biopsy should
be performed for diagnosis. An excisional biopsy should be carried out with a thorough
plan after a complete imaging evaluation. The evaluation of physiologic discharge or
galactorrhea is primarily an assessment of endocrine factors.
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Introduction
Nipple discharge is usually defined as fluid that
escapes spontaneously from the nipple, while fluid
in the ducts that must be collected by aspiration,
suction or massage, i.e. does not escape spontane-
ously, is referred to as “secretion”. Nipple discharge
has been reported in 10–15% of women with benign
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breast diseases, and in about 1–3% of those with
breast cancer [1,2]. The discharge, according to its
appearance, can be described as milky, serous,
greenish, brown, colored, cloudy, purulent, sero-
sanguineous, or bloody. Among these, bloody dis-
charge is the most worrisome because of its asso-
ciation with papillary lesions or carcinoma (Fig. 1).
Only 4% of women with nipple discharge have
breast cancer [3], although the reported incidences
vary greatly [4–8]. However, in patients with bloody
or serous nipple discharge, there is a higher prev-
alence of carcinoma, papilloma or other papillary
lesions (74%). The majority (94%) of patients having
fluid with secretory components were associated
with fibrocystic changes and other nonproliferative
breast lesions; only 6% were associated with pap-
illomas [9]. It is, therefore, very important to eval-
uate the clinical significance of nipple discharge,
especially when there is no palpable mass [9].
Clinical Evaluation of Nipple Discharge
Spontaneous nipple discharge is often ignored.
Women search for medical help usually because
of colored or bloody discharge. Generally, only a
small percentage of women with nipple discharge
are found to have malignancy. The majority of dis-
charges are caused by benign conditions such as
fibrocystic changes, duct ectasia, benign papilloma
or other papillary lesions, or other nonproliferative
lesions [9,10]. Evaluation of the discharge is mainly
based on a careful history, physical examination,
specific imaging studies, cytologic studies, and/or
histopathologic studies.
History
A history of nipple discharge in association with a
self-discovered mass is suggestive of neogrowth or
cancer. The clinically significant discharge is usually
spontaneous, not a result of forcible manual com-
pression or passive induction. The discharge is also
significant if it is unilateral, or localized to a single
quadrant or a single duct, and occurs in an older
woman. Discharges associated with cancer can be
bloody, watery, serous or serosanguineous. Dischar-
ges due to benign causes are frequently bilateral
and multiductal, and are usually milky, green or
greenish blue [11]. Discharge as a sole finding with-
out any palpable mass is rarely related to breast
cancer [2]. Nipple discharge in a patient carrying
risk factors such as a family history of breast cancer
on the maternal side, or a past history of breast
cancer, requires more vigilant investigation or close
surveillance.
Physical Examination
In addition to routine inspection and palpation of
the entire breast and lymph node-bearing area,
the nipple-areola complex should be carefully in-
spected for subtle changes in the surface, retro-
areolar masses, and nipple discharge [3]. The phy-
sical examination is performed by first squeezing
the nipple between the finger and thumb to check
the character of the discharge. Then, the nipple is
cleaned, and further forcible manual compression
is applied to the breast from the peripheral to the
central part according to the different clock directions,
preferably radially in a clockwise fashion starting
from the 12 o’clock position. A diagram is used to
record the location of the duct or quadrant related
to the discharge. We prefer to localize any mass
or abnormalities along a specific radial of a clock
on the breast in centimeters from the margin of
the nipple attachment. The suspected area of ab-
normality can be marked on the skin with a skin
marker, so that imaging studies can be correlated
with the physical findings.
Specific Imaging Studies
Mammography
The majority of physicians agree that mammo-
graphy is an effective screening tool. The benefit
of detecting a small cancer using screening mam-
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mography far outweighs any theoretical risk [12,
13]. Therefore, in patients with nipple discharge,
mammography is indicated if the woman is older
than 40 years, especially when the patient has
never had a mammography before the episode of
discharge. Mammography may not demonstrate
small intraductal nodules such as small papillomas
or carcinomas which are not calcified. Dilated ducts
caused by relatively small intraductal pathology
in the subareolar region can be depicted (Fig. 2).
Generally, the state-of-the-art ultrasound machine
can provide high-resolution imaging to detect a di-
lated duct and, frequently, intraductal pathologies.
We prefer to perform ultrasound first. Information
from physical examination should be obtained be-
fore imaging, preferably with skin markings of any
abnormalities suspected.
Ultrasound
Ultrasound has frequently been used as an adjunct
to mammography in the diagnosis of breast diseases.
It is most useful and accurate in the evaluation of
dense breasts, when mammography has low sen-
sitivity in tumor detection, and in differentiating
between cystic and solid masses. By using state-of-
the-art ultrasound scanners, small solid nodules
that are even smaller than 5 mm can be visualized,
and dilated ducts can be easily depicted (Fig. 3).
The presence of intraductal echoes might suggest
inspissated milk or a solid tumor, depending on
the echogenicity and morphology of the intraduc-
tal echoes (Figs. 4–6). Generally, a breast with phy-
siologic nipple discharge contains multiple dilated
ducts, rather than a single duct as in pathologic dis-
charge. The fluid inside the ducts is usually anechoic
or very hypoechoic. In patients with pathologic dis-
charge related to malignant tumors, the lesion, if
identifiable on ultrasound, can be inside the dilated
duct, adjacent to it, or invading into the duct and
distending the lumen (Fig. 7). Color Doppler ultra-
sound can further provide information of the blood
flow signals inside or peripheral to the dilated duct.
When there are color flow signals in the intraductal
echogenic nodule, neogrowth should be considered
(Fig. 8). Contrast-enhanced ultrasound may increase
the sensitivity in tumor detection and diagnostic
confidence in color or power Doppler mode (Figs.
9 and 10).
Galactography
Injection of water-soluble iodinated contrast into
the ducts via the duct opening may demonstrate
Fig. 2. Mammograms of a 57-year-old woman with nipple discharge: (A) medio-
lateral oblique view shows prominent ducts (arrows) in the subareolar region;
(B) magnified view better demonstrates the prominent ducts (arrows).
  A B
Fig. 1. Typical clinical presentation
of bloody discharge from the nipple
(arrow).
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  A B
Fig. 3. Dilated ducts in a lactating woman: (A) the ducts are smoothly dilated or mildly irregular in caliber; (B) the contents
are usually echo-free or show only low-level echoes.
Fig. 5. A single dilated duct (arrow) located in the subareo-
lar region contains an ovoid solid tumor (arrowhead) corres-
ponding to an intraductal papilloma.
Fig. 6. Three-dimensional ultrasound demonstrates a mini-
mally prominent duct (arrow) with a solid tumor (arrowhead)
located in the more peripheral portion. Surgical resection of
the tumor confirmed the diagnosis of intraductal papilloma.
Fig. 4. Dilated ducts in a 62-year-old woman contain concretions of inspissated milk (arrows): (A) left breast; (B) right
breast – color Doppler ultrasound cannot demonstrate any color flow signal in the echogenic nodules in the ducts.
  A B
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duct ectasia, obstruction, galactocele or filling de-
fects (Figs. 11–13). This test is useful in experienced
hands. A method of combined galactography with
wire localization has been introduced to find pap-
illomas [14], but the procedure is somewhat com-
plicated and there is no reliable means of intraop-
erative verification that the correct tissue has been
removed; it is, therefore, not strongly recommended
nowadays. Even galactography is now seldom used
because it is time-consuming and often painful [15].
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is being studied
to determine its usefulness in diagnosing breast
Fig. 8. A small intraductal papilloma (0.8 = 0.6 cm)
(arrowhead) and a dilated duct (arrows) are shown on color
Doppler ultrasound; the color flow signals in the lesion are
indicative of a solid tumor or a papilloma.
Fig. 9. (A) A nonpalpable small subareolar nodule (0.6
cm) (arrow) contains minimal color flow signals on color
Doppler ultrasound. (B) After intravenous injection of micro-
bubble ultrasonic contrast agent (Levovist®), the nodule is
well enhanced, and profuse color flow signals are demonstrated
20 seconds after contrast injection. The nodule is pathologically
proven to be a papilloma.
  A
  B
  A B
Fig. 7. A 75-year-old woman with serous nipple discharge: (A) ultrasound shows a dilated duct (arrows) in the subareolar
region; (B) while tracing towards a more peripheral portion of the breast, a small hypoechoic lesion with a poorly defined
boundary is found (arrowheads), confirmed pathologically as a ductal carcinoma in situ with microinvasion.
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Fig. 10. A small subareolar intraductal carcinoma (0.8 = 0.6 cm) in a 52-year-old woman with bloody nipple discharge.
(A) Before contrast injection, the lesion (arrow) shows only minimal color flow signals; (B) after contrast injection, profuse
color flow signals are noted in the lesion (arrows).
  A B
Fig. 11. Focal dilatation of ducts in the left breast of a 32-year-old woman with yellowish nipple discharge. (A) Ultra-
sound shows multiple dilated ducts (arrows) in the left upper outer quadrant (mainly at 2 and 3 o’clock directions).
(B) Galactography with injection of water-soluble iodinated contrast agent demonstrates the dilated ducts without visible
intraductal filling defects (arrows).
  A B
Fig. 12. Intraductal papillomas within a single dilated duct. (A) Ultrasound depicts a dilated duct (arrow) and an intralu-
minal nodule (arrowhead), indicating a tumor – most likely papilloma. (B) Galactography shows multiple filling defects
in the dilated duct; more nodules (arrows) can be demonstrated by galactography.
  A B
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masses. Gadolinium contrast is used to enhance the
vascularity of malignant lesions. Although MRI is
highly sensitive (85–100%), it lacks specificity (47–
67%) [16,17]. MRI is inferior to mammography in
detecting in situ cancers and cancers smaller than
3 mm, and it provides no cost benefit over exci-
sional biopsy for verifying malignancy [16,17].
Research suggests two potential roles for MRI in
breast mass diagnosis: evaluating patients with
silicone breast implants [18], and assessing patients
in whom evaluation by ultrasonography and mam-
mography is problematic. There is no concrete
evidence thus far that MRI can be effectively used
in detecting intraductal pathologies, although the
potential definitely exists (Figs. 14–16). There are
limited reports on the MRI characteristics of breasts
with abnormal discharge. Findings including rapid
contrast enhancement of intraductal papillomas or
small luminal mass with nonspecific MRI patterns
have been described [19,20]. In a retrospective re-
view of 15 pathologically proven papillomas, three
patterns were found. Four papillomas were small,
smooth, enhancing masses at the posterior end of
an enlarged duct, corresponding to the “small luminal
mass” appearance of papilloma known from ga-
lactography; two of these “small luminal mass” pap-
illomas in patients with abnormal discharge were
detected on MRI even when galactography was
unsuccessful. Seven papillomas showed irregular
enhancing masses without specifically benign
Fig. 14. A 58-year-old woman with nipple discharge from the left breast and a palpable nodule in the left 2 o’clock direction.
(A) Ultrasound demonstrates the solid tumor (arrowhead) and a minimally dilated duct (arrow) adjacent to it. (B) Dynamic
contrast-enhanced magnetic resonance imaging also shows the rapidly enhanced tumor (arrow), but the adjacent duct is
not shown on T2 imaging.
  A B
Fig. 13. A tiny intraductal papilloma is demonstrated on: (A) ultrasound (arrow); and (B) galactography (arrow).
  A B
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Fig. 16. Dynamic contrast-enhanced
magnetic resonance imaging (MRI)
of the same patient as in Fig. 15.
Early arterial phase, maximum in-
tensity projection: sagittal images of
the (A) right breast and (B) left
breast; (C) axial image of bilateral
breasts; and (D) frontal image. All
demonstrate the rapidly well-enhanced
subareolar papillomas (large arrows)
and other small papillomas (small
arrows). The cancer in the medial
aspect of the right breast is, however,
poorly demonstrated on MRI.
  A C
  B D
Fig. 15. Sonography of the right breast in a 58-year-old woman with confirmed papillomas and cancer. (A) Two hypoechoic
nodules (arrows) in the right subareolar region, measuring 1.0 cm and 0.5 cm. (B) Color Doppler ultrasound of the subareolar
lesions (arrows) demonstrates minimal color flow signals in the larger lesion, while the smaller lesion shows no significant
signals. (C) One of the other small nodules in the breast is also shown (arrow); (D) but no significant color flow signals
can be demonstrated on color Doppler ultrasound. (E) Grayscale and (F) color Doppler ultrasound depict a solid tumor
(arrows) in the right breast over the medial aspect. The lesion has an indistinct boundary and spiculated margin, indicative
of a malignant tumor. Color Doppler ultrasound shows no significant color flow signals in the lesion, but minimally increased
blood flows in the surrounding tissue are evident.
  A C E
  B D F
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findings. All seven demonstrated rapid enhancement
and three showed rim enhancement or speculation.
These “tumor-like” papillomas, however, could not
be distinguished from invasive breast cancer on
MRI. Four papillomas were occult on MRI, not re-
vealed by either contrast-enhanced MRI or fat-
suppressed T2-weighted MRI [17]. On the basis
of these observations, MRI can be of certain aid
in the evaluation of patients with abnormal nipple
discharge that is caused by intraductal papillomas.
Cytologic and Histologic Studies
Nipple discharge / aspirate fluid cytology
Nipple discharge may be episodic, and when the
patient presents herself to the physician, there may
not be spontaneous discharge. In a large propor-
tion of women, fluid in the dilated duct lumens can
be obtained by removing the keratotic plug and
using the “finger-and-thumb” test or a simple nipple
aspirator device [21–23]. After eliciting the discharge,
the aspirate fluid can be smeared onto a glass slide,
fixed, and submitted for cytologic evaluation with
Papanicolaou stain [24]. An air-dried smear with
Wright’s or Liu’s stain may also provide some in-
formation [25]. The cytopathologist or pathologist
who makes the final diagnosis should review all
the available slides. They should make their inter-
pretation based on the cytologic findings, together
with knowledge of the clinical information. The
basic experience can be accumulated partly from
a knowledge of cytologic findings in the discharge
or aspirate fluid of women without breast disease
(i.e. normal or benign findings) [26,27]. Cytology
has been reported to have a false negative rate of
18% and a false positive rate of 2.5% [11].
Ultrasound-guided aspiration cytology
Needle aspiration cytology involves the use of a
fine needle (usually 22 gauge or smaller) with a
syringe to aspirate the contents inside a dilated
duct or to directly target an intraductal nodule to
obtain cells for analysis. The aspirated material can
be smeared onto glass slides and fixed immediately
in 95% ethanol, then stained for cytologic evalu-
ation (Figs. 17 and 18). Some experts also request
air-dried smears. If the procedures of aspiration and
specimen preparation are performed accurately and
the cytopathologist is experienced, a high yield
rate from cytologic study for the diagnosis can be
achieved. A limitation to this technique is the in-
ability to obtain a specific histologic diagnosis [28,
29].
Core needle biopsy
Core needle biopsy (CNB) produces a larger tissue
sample than fine needle aspiration (FNA), and may
be used in conjunction with ultrasonography or
stereotactic imaging for small or difficult-to-palpate
lesions. Local anesthesia is required. A 14- to 18-
gauge cutting needle is used to obtain two to six
Fig. 17. Ultrasound-guided aspiration cytology. (A) Needle insertion and aspiration are monitored by high-resolution
ultrasound. (B) The aspirated fluid or material is sprayed onto a glass slide and then smeared for cytologic study.
  A B
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slender cores of tissue for histology [30,31]. The
sensitivity of ultrasound-guided CNB may be as
high as 99% in diagnosing malignancy in pal-
pable lesions and 93% in nonpalpable lesions
[32]. However, application of CNB for intraductal
contents is not routinely used in our hospital. We
prefer to perform FNA first; if there is any doubt,
CNB or wire localization for surgical removal of the
duct and its contents can be undertaken. Part of
the reason for this is because intraductal pathol-
ogies are usually quite small, and they can be
pushed away by the relatively blunt larger-bore
needle. If a lesion with a size of 4–5 mm or larger
is demonstrated on ultrasound, inside or adjacent
to the duct, or in the breast stroma, then CNB can
be confidently performed (Figs. 19 and 20).
Excisional biopsy
Excisional biopsy can be diagnostic and therapeu-
tic: a completely removed mass with good margins
of normal tissue may mean that further surgery is
not required. Excisional biopsy is indicated in pa-
tients with clinically suspicious lesions and lesions
in which imaging or tissue studies are equivocal
[33,34]. With the increased use of CNB, the need
for diagnostic excisional biopsy has declined, par-
ticularly in malignant tumors [35].
Excisional biopsy should be carried out as part
of a thorough plan, usually starting with a complete
whole breast ultrasound and mammography study.
Fig. 19. Needle biopsy:
devices and procedure.
(A) The needle used in
core needle biopsy (upper
panel) and the biopsy guns
(lower panel). (B) Ultra-
sound-guided needle bio-




  A B
Fig. 18. Needle aspiration targeted at an intraductal tumor (papilloma). (A) The duct is focally dilated in the subareolar
region, with an intraductal solid tumor (arrowhead). (B) The needle tip (arrow) is guided to directly target the tumor
(arrowhead).
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formed (Fig. 21). Planning all incisions and then re-
moval of all the gross evidence of disease (including
dilated duct and nodule), usually with a small rim
of normal breast tissue, should be performed care-
fully, since there can be a need for subsequent sur-
gery if the lesion is found to be malignant on frozen
section.
General Comments on Treatment Plan
As bilateral and multiductal discharge are unlikely
to be associated with cancer, investigations should
basically focus on function tests, serum prolactin
level, and checking for medication history, e.g. hor-
mone replacement therapy, psychotropics and
antihypertensive drugs. Treatment is mainly for the
patient’s underlying conditions. Any discharge
should be routinely checked for occult blood. An
occult blood-positive discharge does not neces-
Fig. 20. A woman with Paget’s disease with oozing from
the nipple. (A) The nipple has an eczematous appearance.
(B) Ultrasound shows microcalcifications in the subareolar
region, probably inside the minimally dilated ducts (arrows).
(C) Histologic study of the biopsy specimens reveals a pattern
of ductal carcinoma in situ with microcalcification (arrow).
If ultrasound shows a dilated duct with a definite
solid nodule inside or adjacent to the dilated duct,
and whole breast ultrasound and mammography
show no other suspicious malignant pathology,




Fig. 21. Wire locali-
zation: (A) the hook
wires and needles;
(B) the excised tissue
shows a papillary tu-
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sarily indicate malignancy, but suggests intraductal
disease. Further studies should be done to detect
intraductal and/or intraparenchymal tumor, espe-
cially if the discharge is from a single duct. If
cytologic study of the discharge or aspirated fluid
shows no evidence of malignant or suspect cells,
and imaging studies do not demonstrate any focal
solid lesion that can be related to the dilated ducts
or occult blood-positive discharge, the patient can
be treated conservatively. However, for patients with
purulent or green and sticky discharge in the absence
of subareolar induration or mass, the administration
of antibiotics should be considered. Women can be
very fearful if they have both nipple discharge and
mastalgia. If all the investigations demonstrate no
evidence of breast tumor, most patients require no
active treatment. In women suspected of having
periductal mastitis, nonsteroidal anti-inflammatory
drugs can be tried [27].
Conclusion
Whenever there is imaging evidence of a focal solid
breast nodule, the treatment plan should follow the
general algorithm for the diagnosis and treatment
of breast cancer. Physicians who are involved in the
diagnosis and treatment of patients with nipple
discharge should remember that delayed diagnosis
of breast cancer has been one of the most expensive
conditions for insurance companies in the United
States since 1995. This may also begin to happen
in Asia. Physicians should take any symptoms of the
patient seriously. Although only a small percentage
of breast malignancy is associated with nipple
discharge, proper investigations should still be
undertaken.
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